These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21176407)

  • 21. Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation.
    Bajada S; Harrison PE; Ashton BA; Cassar-Pullicino VN; Ashammakhi N; Richardson JB
    J Bone Joint Surg Br; 2007 Oct; 89(10):1382-6. PubMed ID: 17957083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of granulocyte colony stimulating factor on T-cell subsets in peripheral blood and its correlation with the mobilization effect of CD34+ cells].
    Xu J; Lu DP; Ji BX; Wan SG; Sun XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):639-41. PubMed ID: 14706150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vivo effect of rhG-CSF on the CXCR-4 expression of hematopoietic progenitor or stem cells in bone marrow and peripheral blood].
    Zhao XY; Chang YJ; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):857-60. PubMed ID: 16277858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D; Gross A; Kosova N; Fichtner I; Salama A
    Transfusion; 2005 Jul; 45(7):1192-200. PubMed ID: 15987366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
    Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis.
    Tei K; Matsumoto T; Mifune Y; Ishida K; Sasaki K; Shoji T; Kubo S; Kawamoto A; Asahara T; Kurosaka M; Kuroda R
    Stem Cells; 2008 Mar; 26(3):819-30. PubMed ID: 18192236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful collection and engraftment of autologous peripheral blood progenitor cells in poorly mobilized patients receiving high-dose granulocyte colony-stimulating factor.
    Cooper DL; Proytcheva M; Medoff E; Seropian SE; Snyder EL; Krause DS; Wu Y
    J Clin Apher; 2012 Nov; 27(5):235-41. PubMed ID: 22566214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor.
    Gordon MY; Levicar N; Pai M; Bachellier P; Dimarakis I; Al-Allaf F; M'Hamdi H; Thalji T; Welsh JP; Marley SB; Davies J; Dazzi F; Marelli-Berg F; Tait P; Playford R; Jiao L; Jensen S; Nicholls JP; Ayav A; Nohandani M; Farzaneh F; Gaken J; Dodge R; Alison M; Apperley JF; Lechler R; Habib NA
    Stem Cells; 2006 Jul; 24(7):1822-30. PubMed ID: 16556705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative association of donor age with CD34⁺ cell dose in mixture allografts of G-CSF-primed bone marrow and G-CSF-mobilized peripheral blood harvests.
    Li Y; Chang Y; Xu L; Zhang X; Huang X
    Chin Med J (Engl); 2014; 127(20):3597-601. PubMed ID: 25316236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.
    Paczkowska E; Larysz B; Rzeuski R; Karbicka A; Jałowiński R; Kornacewicz-Jach Z; Ratajczak MZ; Machaliński B
    Eur J Haematol; 2005 Dec; 75(6):461-7. PubMed ID: 16313257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
    Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes and graft characteristics in pediatric hematopoietic stem cell transplantation: Effect of granulocyte-colony stimulating factor priming.
    Fettah A; Özbek N; Azık F; Tavil B; Özgüner M; Avcı Z; Işık P; Yaralı N; Uçkan D; Tunç B
    Transfus Apher Sci; 2015 Jun; 52(3):332-8. PubMed ID: 25779226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superior Potential of CD34-Positive Cells Compared to Total Mononuclear Cells for Healing of Nonunion Following Bone Fracture.
    Fukui T; Mifune Y; Matsumoto T; Shoji T; Kawakami Y; Kawamoto A; Ii M; Akimaru H; Kuroda T; Horii M; Yokoyama A; Alev C; Kuroda R; Kurosaka M; Asahara T
    Cell Transplant; 2015; 24(7):1379-93. PubMed ID: 24800622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobilization of hematopoietic stem cells with highest self-renewal by G-CSF precedes clonogenic cell mobilization peak.
    Winkler IG; Wiercinska E; Barbier V; Nowlan B; Bonig H; Levesque JP
    Exp Hematol; 2016 Apr; 44(4):303-14.e1. PubMed ID: 26827874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
    Steen R; Tjønnfjord GE; Egeland T
    J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies.
    Hamadani M; Kochuparambil ST; Osman S; Cumpston A; Leadmon S; Bunner P; Watkins K; Morrison D; Speir E; Deremer D; Kota V; Jillella A; Craig M; Awan F
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1128-35. PubMed ID: 22248715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.